Safety and Efficacy of 'Interleukin' in Severe Infectious Disease Patients!! Catching Two Rabbits!

Those who applied for hit the daily limit price in just one day! Achieved 31% profit!

Congratulations to everyone who applied for the free trial. ^^

※ For those who missed the “COVID-19 treatment” opportunity, it’s okay. We are going out strong once again.

※ Finally starting. Bodytech Med (206640) follow-up stock will hit the daily limit price on Monday. ※

▶▶ Starting big with the ‘daily limit price’ on August 31, related to interleukin safety and efficacy! ‘ㅇㅇㅇㅇ’ related stocks! ▶ Apply for free trial ◀

Genexine reported that in COVID-19 patients, the number of T cells decreases as the severity increases, and the higher the degree of decrease, the higher the fatality rate. Interleukin-7 is the only T cell proliferation factor that can increase T cell count and is currently under clinical development targeting cancer and infected patients!!

Recent clinical trials conducted in the UK on severe COVID-19 patients confirmed that interleukin-7 safely increases T cell counts without causing side effects such as cytokine storms. Additionally, the secondary infection rate was 58%, about 27% lower than the 85% rate in patients who received only standard treatment without interleukin-7!!

▶▶ Heading straight ‘up’ on Monday. Moving fast. Prepare for interleukin safety and efficacy related beneficiary stocks! Don’t miss out [Apply now for ‘interleukin safety and efficacy’ related stocks]

“I applied and bought small amounts every day for 3 days, and was amazed to see daily limit price profits every day. I was really surprised. It’s amazing how this is possible. It’s been about 3 months since I paid the membership fee and received VIP service, and already 30 million KRW has accumulated in my account. Thank you so much again. Ah! I am actively recommending it to my acquaintances as well.”

(VIP office worker Yoo Jin Lee, 41 years old member)

Now think of this as the last chance. If you miss this opportunity, you have to quit.

Exactly on “August 31” it will explode! Don’t miss out and regret it, buy even with just 1 million KRW!

▶▶ “August 31 daily limit price” offer ends today only. [Receive ‘interleukin safety and efficacy’ related stocks!] ▶ Receive stocks ◀

[AI recent daily limit price hits]

*20.08.27 Bodytech Med (206640) hit daily limit!

*20.08.26 Telcon RF Pharmaceutical (200230) hit daily limit!

*20.08.25 Woori Bio (082850) hit daily limit!

*20.08.24 Jinwon Life Science (011000) hit daily limit!

*20.08.21 Exaienc (054940) hit daily limit!

*20.08.20 Wooridul Pharmaceutical (004720) 3 consecutive daily limits hit!

*20.08.19 Wooridul Pharmaceutical (004720) 2 consecutive daily limits hit!